Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

FDA grants priority review to Hemlibra sBLA

June 5, 2018

Transfusion reductions seen with stem cell gene therapy for beta-thalassemia

June 1, 2018

Astellas and FibroGen announce topline data from Japanese phase III study of roxadustat

June 1, 2018

Doptelet becomes available in the U.S. for the treatment of thrombocytopenia

June 1, 2018

FDA places clinical hold on IND for CTX-001 in sickle cell disease

May 31, 2018

Tavalisse becomes available in the U.S.

May 30, 2018

European designation decisions for BioCryst's BCX-7353 for HAE

May 25, 2018

Portola Pharmaceuticals receives milestone payment following Andexxa approval

May 25, 2018

FDA accepts supplemental BLA and grants priority review for pediatric use of Coagadex

May 24, 2018

Hemlibra subcutaneous injection now available in Japan

May 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...